Advanced Signals

LifeSphere Advanced Signals is a safety signaling solution from ArisGlobal, designed for life sciences organizations involved in signal and risk management. It covers end-to-end signaling workflows and incorporates generative AI capabilities through NavaX, along with case and context evaluation tools delivered via a module called Signals Intelligence. The platform targets pharmacovigilance teams seeking to reduce false positives, accelerate benefit-risk evaluation, and identify potential safety issues earlier.

ArisGlobal's LifeSphere technology is used by more than 220 global life sciences companies, contract research organizations, and government health authorities, including regulatory bodies such as the FDA, Health Canada, and NMPA.

Core Capabilities

• Automated and streamlined end-to-end signaling workflows to accelerate signal management and benefit-risk evaluation.
• Reduction of false positives through advanced automation tools and signal management methods applied across multiple data sources.
• Integration with third-party systems and data sources via a system-agnostic platform, reducing IT overhead and complexity.
• Accelerated access to safety insights intended to support proactive identification of potential patient risks.

Features

• Out-of-the-Box Automation: Includes pre-built signal classification and management workflows to process signals with greater accuracy.
• Fine-Grain Signal Detection: Supports a wide range of quantitative and qualitative statistical methods for more accurate signal detection.
• Integrated Data Connectivity: Offers out-of-the-box connectors to both private and public data sources for signal detection on a system-agnostic platform.
• Built-In Literature Review: Automates identification of relevant publications to support signal detection, validation, and aggregate report preparation.
• GenAI-Powered Signals Intelligence: Uses generative AI and knowledge graphs to create visualizations of relationships between case attributes, supporting case and context evaluation.
• Robust Signaling Analytics: Provides advanced product and comparative analytics for trend recognition and focused evaluation.
• Case Completeness Score: A scoring mechanism that helps prioritize high-quality and well-documented cases to improve precision and speed in case evaluation.
• Automated Notifications: Delivers tailored automated notifications to internal teams and external stakeholders, including the Qualified Person for Pharmacovigilance (QPPV).

Platform and Deployment Context

• LifeSphere Advanced Signals is part of ArisGlobal's broader LifeSphere modular safety solutions portfolio, which is described as GenAI-powered.
• The platform is positioned as system-agnostic, supporting integration with a range of external data sources and third-party systems.
• ArisGlobal is headquartered in the United States and maintains regional offices in Europe, India, Japan, and China, supporting global life sciences customers.